Therapeutic Potential of Edaravone for Neuroprotection Following Global Cerebral Hypoxia.

Int J Mol Sci · 2025 · PMC12469665 · PMID 41009582

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp < 0.0001actually significant

S100B showed a highly significant ( p < 0.0001) upregulation in the treated hypoxia group (2.114 ± 0.7348) compared to the control group (0.4455 ± 0.1956), whereas the untreated hypoxia group (0.8149 ± 0.4930) was similar to the control group (0.4455 ± 0.1956).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.